BioCentury
ARTICLE | Clinical News

Chromagen regulatory update

November 4, 1996 8:00 AM UTC

Chromagen received notice of allowance for a U.S. patent covering a composition of matter for fluorescent nucleotide analogs and the uses of the analogs to create internally and end-labeled DNA and RN...